Medication info
Ibatron Tablet 150mg (Ibandronic Acid Sodium Monohydrate)

Ibatron Tablet 150mg (Ibandronic Acid Sodium Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Ibandronate Sodium Monohydrate›168.75mg / 1 tablet
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
White to almost white rectangular film-coated tablet
Packaging
1 tablet/PTP
Approval status
Active

MFDS item code 201208995 · Approved 2012.11.30 · Insurance code 651203800

Summary

Main use
Treatment of osteoporosis in postmenopausal women
Who takes it
Adults · Children
Adult dose
Take 1 tablet once a month, regularly on the same day each month in the morning, with plenty of water at least 1 hour before consuming food, beverages (except water), or other oral medications or dietary supplements (including calcium): - Swallow this medicine with a sufficient amount of water (180-240ml) while standing or sitting upright, and do not lie down for 60 minutes after taking it. - Mineral water may reduce absorption of this medicine; take it with plain water. - Do not chew or suck the tablet, to avoid esophageal ulcers. If a patient forgets to take the medicine on the regularly scheduled day: - If 8 days or more remain until the next regularly scheduled dose, take 1 tablet the next morning after realizing that the dose was missed, then continue taking 1 tablet monthly on the previously scheduled day. - If 7 days or fewer remain until the next regularly scheduled dose, take 1 tablet on the next regularly scheduled day, then continue taking 1 tablet monthly on the previously scheduled day. - Do not take 2 tablets in the same week. Patients with inadequate dietary intake should supplement calcium or vitamin D, etc. Patients with hepatic impairment No dosage adjustment is necessary Patients with renal impairment No dosage adjustment is necessary in patients with mild or moderate renal impairment with a creatinine clearance of 30mL/min or higher. Use of this medicine is not recommended in patients with a creatinine clearance below 30mL/min because clinical experience is insufficient. Older adults No dosage adjustment is necessary.
Child dose
Efficacy and safety have not been studied in children 18 years of age or younger.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used to treat osteoporosis that may occur in postmenopausal women, a condition where bones weaken and are at risk of breaking easily. It helps to prevent bone density loss, reducing the risk of fractures and maintaining healthy bones. Therefore, it is effective for the treatment of osteoporosis in postmenopausal women.

How to take

Adult dose

Take 1 tablet once a month, regularly on the same day each month in the morning, with plenty of water at least 1 hour before consuming food, beverages (except water), or other oral medications or dietary supplements (including calcium): - Swallow this medicine with a sufficient amount of water (180-240ml) while standing or sitting upright, and do not lie down for 60 minutes after taking it. - Mineral water may reduce absorption of this medicine; take it with plain water. - Do not chew or suck the tablet, to avoid esophageal ulcers. If a patient forgets to take the medicine on the regularly scheduled day: - If 8 days or more remain until the next regularly scheduled dose, take 1 tablet the next morning after realizing that the dose was missed, then continue taking 1 tablet monthly on the previously scheduled day. - If 7 days or fewer remain until the next regularly scheduled dose, take 1 tablet on the next regularly scheduled day, then continue taking 1 tablet monthly on the previously scheduled day. - Do not take 2 tablets in the same week. Patients with inadequate dietary intake should supplement calcium or vitamin D, etc. Patients with hepatic impairment No dosage adjustment is necessary Patients with renal impairment No dosage adjustment is necessary in patients with mild or moderate renal impairment with a creatinine clearance of 30mL/min or higher. Use of this medicine is not recommended in patients with a creatinine clearance below 30mL/min because clinical experience is insufficient. Older adults No dosage adjustment is necessary.

Child dose

Efficacy and safety have not been studied in children 18 years of age or younger.

Precautions

This medication should not be used by certain patients. For example, those allergic to this medicine or its components, untreated hypocalcemia patients, those who cannot sit or stand upright for more than 60 minutes, patients with esophageal function issues that hinder swallowing, and individuals with lactose intolerance or genetic metabolic disorders should not take this medication. Patients with severe renal impairment should be particularly cautious when using this medication. If kidney function is significantly diminished, the effects of the drug may vary. While taking this medication, mild to moderate side effects such as dyspepsia, nausea, abdominal pain, diarrhea, headache, myalgia, arthralgia, and rash may occur. Most of these symptoms are mild to moderate and often do not require discontinuation of treatment. In rare cases, patients may experience symptoms such as esophagitis, esophageal ulcers, dysphagia, dizziness, back pain, angioedema, or urticaria, in which case they should consult a medical professional. This medication may irritate the esophagus and gastric mucosa, thus it is important to remain upright for at least 60 minutes after taking it and not to take it with food or other medications. Additionally, calcium and vitamin D levels should be adequately managed prior to using this medication, and it should be taken at an interval from any drugs that may interfere with absorption, such as calcium, antacids, or iron supplements. Severe side effects such as osteonecrosis of the jaw have been reported, so it is recommended to consult with healthcare providers before undergoing dental treatment and to avoid excessive dental procedures during treatment. It is advised not to use this medication during pregnancy or breastfeeding. Safety in children and adolescents under 18 years of age has not been established. In cases of overdose, gastrointestinal disturbances or hypocalcemia may occur, and vomiting should not be induced; the patient should be kept sitting or standing. This medication should be kept out of reach of children, and expired medicines should be disposed of properly to avoid environmental harm.

Side effects

dyspepsia, nausea, abdominal pain, diarrhea, bloating, gastroesophageal reflux disease, headache, influenza-like illness, fatigue, myalgia, arthralgia, rash, gastritis, esophagitis, muscle spasm, musculoskeletal pain, musculoskeletal stiffness, dysphagia, vomiting, esophageal ulcer, esophageal stricture, dizziness, low back pain, duodenitis, hypersensitivity reaction, angioedema, facial edema, urticaria, uveitis, scleritis, osteonecrosis of the jaw and external auditory canal, anaphylactic reaction, shock, allergic reaction, Stevens-Johnson syndrome, erythema multiforme, vesicular dermatitis, atypical subtrochanteric fracture, intertrochanteric femoral fracture, visual disturbances, weakness, pruritus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should ideally be room temperature between 1°C and 30°C. This ensures the medication's efficacy is maintained for a longer period.

Appearance and packaging

Appearance

White to almost white rectangular film-coated tablet

Package unit

1 tablet/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.